A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)

T.S. Waddell, I. Chau, Y. Barbachano, D.G. de Castro, A. Wotherspoon, C. Saffery, G.W. Middleton, J. Wadsley, D.R. Ferry, W. Mansoor, T.D.L. Crosby, F.Y. Coxon, D. Smith, J.S. Waters, T. Iveson, S. Falk, S. Slater, A.F.C. Okines, D. Cunningham

Research output: Contribution to conferenceOtherpeer-review

Original languageEnglish
Publication statusPublished - 20 Jun 2012

Cite this